Browsing by Author "Guldemond, N"

Now showing 1 - 5 of 5
  • No Thumbnail Available
    Item
    Next-generation care pathways for allergic rhinitis and asthma multimorbidity: a model for multimorbid non-communicable diseases-Meeting Report (Part 2)
    Bousquet, J; Pham-Thi, N; Bedbrook, A; Agache, I; Annesi-Maesano, I; Ansotegui, I; Anto, JM; Bachert, C; Benveniste, S; Bewick, M; Billo, N; Bosnic-Anticevich, S; Bosse, I; Brusselle, G; Calderon, MA; Canonica, GW; Caraballo, L; Cardona, V; Carriazo, AM; Cash, E; Cecchi, L; Chu, DK; Colgan, E; Costa, E; Cruz, AA; Czarlewski, W; Durham, S; Ebisawa, M; Erhola, M; Fauquert, JL; Fokkens, WJ; Fonseca, JA; Guldemond, N; Iinuma, T; Illario, M; Klimek, L; Kuna, P; Kvedariene, V; Larenas-Linneman, D; Laune, D; Le, LTT; Lourenço, O; Malva, JO; Marien, G; Menditto, E; Mullol, J; Münter, L; Okamoto, Y; Onorato, GL; Papadopoulos, NG; Perala, M; Pfaar, O; Phillips, A; Phillips, J; Pinnock, H; Portejoie, F; Quinones-Delgado, P; Rolland, C; Rodts, U; Samolinski, B; Sanchez-Borges, M; Schünemann, HJ; Shamji, M; Somekh, D; Togias, A; Toppila-Salmi, S; Tsiligianni, I; Usmani, O; Walker, S; Wallace, D; Valiulis, A; Van der Kleij, R; Ventura, MT; Williams, S; Yorgancioglu, A; Zuberbier, T
  • No Thumbnail Available
    Item
    Adherence to treatment in allergic rhinitis using mobile technology. The MASK Study
    Menditto, E; Costa, E; Midao, L; Bosnic-Anticevich, S; Novellino, E; Bialek, S; Briedis, V; Mair, A; Rajabian-Soderlund, R; Arnavielhe, S; Bedbrook, A; Czarlewski, W; Annesi-Maesano, I; Anto, JM; Devillier, P; De Vries, G; Keil, T; Sheikh, A; Orlando, V; Larenas-Linnemann, D; Cecchi, L; De Feo, G; Illario, M; Stellato, C; Fonseca, J; Malva, J; Morais-Almeida, M; Pereira, AM; Todo-Bom, AM; Kvedariene, V; Valiulis, A; Bergmann, KC; Klimek, L; Mösges, R; Pfaar, O; Zuberbier, T; Cardona, V; Mullol, J; Papadopoulos, NG; Prokopakis, EP; Bewick, M; Ryan, D; Roller-Wirnsberger, RE; Tomazic, PV; Cruz, AA; Kuna, P; Samolinski, B; Fokkens, WJ; Reitsma, S; Bosse, I; Fontaine, JF; Laune, D; Haahtela, T; Toppila-Salmi, S; Bachert, C; Hellings, PW; Melén, E; Wickman, M; Bindslev-Jensen, C; Eller, E; O'Hehir, RE; Cingi, C; Gemicioglu, B; Kalayci, O; Ivancevich, JC; Bousquet, J; Bousquet, J; Hellings, PW; Aberer, W; Agache, I; Akdis, CA; Akdis, M; Aliberti, MR; Almeida, R; Amat, F; Angles, R; Annesi-Maesano, I; Ansotegui, IJ; Anto, JM; Arnavielle, S; Asayag, E; Asarnoj, A; Arshad, H; Avolio, F; Bacci, E; Bachert, C; Baiar-Dini, I; Barbara, C; Barbagallo, M; Baroni, I; Barreto, BA; Basagana, X; Bateman, ED; Bedolla-Barajas, M; Bedbrook, A; Bewick, M; Beghé, B; Bel, EH; Bergmann, KC; Bennoor, KS; Benson, M; Bertorello, L; Bialoszewski, AZ; Bieber, T; Bialek, S; Bindslev-Jensen, C; Bjermer, L; Blain, H; Blasi, F; Blua, A; Marciniak, MB; Bogus-Buczynska, I; Boner, AL; Bonini, M; Bonini, S; Bosnic-Anticevich, CS; Bosse, I; Bouchard, J; Boulet, LP; Bourret, R; Bousquet, P; Braido, F; Briedis, V; Brightling, CE; Brozek, J; Bucca, C; Buhl, R; Buonaiuto, R; Panaitescu, C; Cabanas, MTB; Burte, E; Bush, A; Caballero-Fonseca, F; Caillaud, D; Caimmi, D; Calderon, MA; Camargos, PAM; Camuzat, T; Canfora, G; Canonica, GW; Cardona, V; Carlsen, KH; Carreiro-Martins, P; Carriazo, AM; Carr, W; Cartier, C; Casale, T; Castellano, G; Cecchi, L; Cepeda, AM; Chavannes, NH; Chen, Y; Chiron, R; Chivato, T; Chkhartishvili, E; Chuchalin, AG; Chung, KF; Ciaravolo, MM; Ciceran, A; Cingi, C; Ciprandi, G; Coehlo, ACC; Colas, L; Colgan, E; Coll, J; Conforti, D; De Sousa, JC; Cortés-Grimaldo, RM; Corti, F; Costa, E; Mc Costa-Dominguez; Al Courbis; Cox, L; Crescenzo, M; Cruz, AA; Custovic, A; Czarlewski, W; Dahlen, SE; D'Amato; Dario, C; da Silva, J; Dauvilliers, Y; Darsow, U; De Blay, F; De Carlo, G; Dedeu, T; Emerson, MDF; De Feo, G; De Vries, G; De Martino, B; Rubina, NPM; Deleanu, D; Demoly, P; Denburg, J; Devillier, P; Ercolano, SDC; Di Carluccio, N; Didier, A; Dokic, D; Dominguez-Silva, MG; Douagui, H; Dray, G; Dubakiene, R; Durham, SR; Du Toit, G; Dykewicz, MS; El-Gamal, Y; Eklund, P; Eller, E; Emuzyte, R; Farrell, J; Farsi, A; De Mello, JF; Ferrero, J; Fink-Wagner, A; Fiocchi, A; Fok-Kens, WJ; Fonseca, J; Fontaine, JF; Forti, S; Fuentes-Perez, JM; Gálvez-Romero, JL; Gamkrelidze, A; Garcia-Aymerich, J; Garcia-Cobas, CY; Garcia-Cruz, MH; Gemicioglu, B; Genova, S; Christoff, G; Gereda, JE; Van Wijk, RG; Gomez, RM; Gómez-Vera, J; Diaz, SG; Gotua, M; Grisle, I; Guidacci, M; Guldemond, N; Gutter, Z; Guzmán, M; Haahtela, T; Hajjam, J; Hernández, L; Houri-Hane, J; Huerta-Villalobos, YR; Humbert, M; Iaccarino, G; Illario, M; Ispayeva, Z; Ivancevich, JC; Jares, E; Jassem, E; Johnston, SL; Joos, G; Jung, KS; Just, J; Jutel, M; Kaidashev, I; Kalayci, O; Kalyoncu, AF; Karjalainen, J; Kardas, P; Keil, T; Keith, PK; Khaitov, M; Khaltaev, N; Kleine-Tebbe, J; Klimek, L; Kowalski, ML; Kuitunen, M; Kull, I; Kuna, P; Kupczyk, M; Kvedariene, V; Krzych-Falta, E; Lacwik, P; Larenas-Linnemann, D; Laune, D; Lauri, D; Lavrut, J; L, TT; Lessa, M; Levato, G; Li, J; Lieberman, P; Liplec, A; Lipworth, B; Carlsen, KCL; Louis, R; Lourenco, O; Luna-Pech, JA; Magnan, A; Mahboub, B; Maier, D; Mair, A; Majer, I; Malva, J; Mandajieva, E; Manning, P; Keenoy, EDM; Marshall, GD; Masjedi, MR; Maspero, JF; Mathieu-Dupas, E; Campos, JJM; Al Matos; Maurer, M; Mavale-Manuel, S; Mayora, O; Medina-Avalos, MA; Melén, E; Melo-Gomes, E; Meltzer, E; Menditto, E; Mercier, J; Miculinic, N; Mihaltan, F; Milenkovic, B; Moda, G; Mogica-Martinez, MD; Mohammad, Y; Momas, I; Monte-Fort, S; Monti, R; Bogado, DM; Morais-Almeida, M; Morato-Castro; Mösges, R; Mota-Pinto, A; Santo, PM; Mullol, J; Münter, L; Muraro, A; Murray, R; Naclerio, R; Nadif, R; Nalin, M; Napoli, L; Namazova-Baranova, L; Neffen, H; Niedeberger, V; Nekam, K; Neou, A; Nieto, A; Nogueira-Silva, L; Nogues, M; Novellino, E; Nyembue, T; O'Hehir, R; Odzhakova, C; Ohta, K; Okamoto, Y; Okubo, K; Onorato, GL; Cisneros, MO; Ouedraogo, S; Pali-Schöll, I; Palkonen, S; Panzner, P; Papadopoulos, NG; Park, HS; Papi, A; Passalacqua, G; Paulino, E; Pawankar, R; Pedersen, S; Pépin, JL; Pereira, AM; Persico, M; Pfaar, O; Phillips, J; Picard, R; Pigearias, B; Pin, I; Pitsios, C; Plavec, D; Pohl, W; Popov, TA; Portejoie, F; Potter, P; Pozzi, AC; Price, D; Prokopakis, EP; Puy, R; Pugin, B; Ross, REP; Przemecka, M; Rabe, KF; Raciborski, F; Raja-Bian-Soderlund, R; Reitsma, S; Ribeirinho, I; Rimmer, J; Riv-Ero-Yeverino, D; Rizzo, JA; Rizzo, MC; Robalo-Cordeiro, C; Rodenas, F; Rodo, X; Gonzalez, MR; Rodriguez-Mañas, L; Rolland, C; Valle, SR; Rodriguez, MR; Romano, A; Rodriguez-Zagal, E; Rolla, G; Roller-Wirnsberger, RE; Romano, M; Rosado-Pinto, J; Rosario, N; Rottem, M; Ryan, D; Sagara, H; Salimäki, J; Samolinski, B; Sanchez-Borges, M; Sastre-Dominguez, J; Scadding, GK; Schunemann, HJ; Scichilone, N; Schmid-Grendelmeier, P; Serpa, FS; Shamai, S; Sheikh, A; Sierra, M; Simons, FER; Sir-Oux, V; Sisul, JC; Skrindo, I; Solé, D; Somekh, D; Sonder-Mann, M; Sooronbaev, T; Sova, M; Sorensen, M; Sorlini, M; Spranger, O; Stellato, C; Stelmach, R; Stukas, R; Sunyer, J; Strozek, J; Szylling, A; Tebyricá, J; Thibaudon, M; To, T; Todo-Bom, A; Tomazic, PV; Toppila-Salmi, S; Trama, U; Triggiani, M; Ulrik, CS; Urrutia-Pereira, M; Valenta, R; Valero, A; Valiulis, A; Valovirta, E; Van Eerd, M; Van Ganse, E; Van Hague, M; Vandenplas, O; Ventura, MT; Vezzani, G; Vasankari, T; Vatrella, A; Verissimo, MT; Viart, F; Viegi, G; Vicheva, D; Vontetsianos, T; Wagenmann, M; Walker, S; Wallace, D; Wang, DY; Waserman, S; Werfel, T; Westman, M; Wickman, M; Williams, DM; Williams, S; Wilson, N; Wright, J; Wroczynski, P; Yakovliev, P; Yawn, BP; Yiallouros, PK; Yorgancioglu, A; Yusuf, OM; Zar, HJ; Zhang, L; Zhong, N; Zernotti, ME; Zhanat, I; Zidarn, M; Zuberbier, T; Zubrinich, C; Zurkuhlen, A
    Background: Mobile technology may help to better understand the adherence to treatment. MASK-rhinitis (Mobile Airways Sentinel NetworK for allergic rhinitis) is a patient-centred ICT system. A mobile phone app (the Allergy Diary) central to MASK is available in 22 countries. Objectives: To assess the adherence to treatment in allergic rhinitis patients using the Allergy Diary App. Methods: An observational cross-sectional study was carried out on all users who filled in the Allergy Diary from 1 January 2016 to 1 August 2017. Secondary adherence was assessed by using the modified Medication Possession Ratio (MPR) and the Proportion of days covered (PDC) approach. Results: A total of 12143 users were registered. A total of 6949 users reported at least one VAS data recording. Among them, 1887 users reported >= 7 VAS data. About 1195 subjects were included in the analysis of adherence. One hundred and thirty-six (11.28%) users were adherent (MPR >= 70% and PDC <= 1.25), 51 (4.23%) were partly adherent (MPR >= 70% and PDC = 1.50) and 176 (14.60%) were switchers. On the other hand, 832 (69.05%) users were non-adherent to medications (MPR <70%). Of those, the largest group was non-adherent to medications and the time interval was increased in 442 (36.68%) users. Conclusion and clinical relevance: Adherence to treatment is low. The relative efficacy of continuous vs on-demand treatment for allergic rhinitis symptoms is still a matter of debate. This study shows an approach for measuring retrospective adherence based on a mobile app. This also represents a novel approach for analysing medication-taking behaviour in a real-world setting.
  • No Thumbnail Available
    Item
    Next-generation care pathways for allergic rhinitis and asthma multimorbidity: a model for multimorbid non-communicable diseases
    Bousquet, J; Nhân, PT; Bedbrook, A; Agache, I; Annesi-Maesano, I; Ansotegui, I; Anto, JM; Bachert, C; Benveniste, S; Bewick, M; Billo, N; Bosnic-Anticevich, S; Bosse, I; Brusselle, G; Calderon, MA; Canonica, GW; Caraballo, L; Cardona, V; Carriazo, AM; Cash, E; Cecchi, L; Chu, DK; Colgan, E; Costa, E; Cruz, AA; Czarlewski, W; Durham, S; Ebisawa, M; Erhola, M; Fauquert, JL; Fokkens, WJ; Fonseca, JA; Guldemond, N; Iinuma, T; Illario, M; Klimek, L; Kuna, P; Kvedariene, V; Larenas-Linneman, D; Laune, D; Le, LTT; Lourenço, O; Malva, JO; Marien, G; Menditto, E; Mullol, J; Münter, L; Okamoto, Y; Onorato, GL; Papadopoulos, NG; Perala, M; Pfaar, O; Phillips, A; Phillips, J; Pinnock, H; Portejoie, F; Quinones-Delgado, P; Rolland, C; Rodts, U; Samolinski, B; Sanchez-Borges, M; Schünemann, HJ; Shamji, M; Somekh, D; Togias, A; Toppila-Salmi, S; Tsiligianni, I; Usmani, O; Walker, S; Wallace, D; Valiulis, A; Van der Kleij, R; Ventura, MT; Williams, S; Yorgancioglu, A; Zuberbier, T
  • No Thumbnail Available
    Item
    THE REFERENCE SITE COLLABORATIVE NETWORK OF THE EUROPEAN INNOVATION PARTNERSHIP ON ACTIVE AND HEALTHY AGEING
    Bousquet, J; Illario, M; Farrell, J; Batey, N; Carriazo, AM; Malva, J; Hajjam, J; Colgan, E; Guldemond, N; Perala-Heape, M; Onorato, GL; Bedbrook, A; Leonardini, L; Stroetman, V; Birov, S; Abreu, C; Abrunhosa, A; Agrimi, A; Alalääkkölä, T; Allegretti, N; Alonso-Trujillo, F; Alvarez-Benito, M; Angioli, S; Apóstolo, J; Armitage, G; Arnavielhe, S; Baena-Parejo, MI; Bamidis, PD; Balenovic, A; Barbolini, M; Baroni, I; Blain, H; Bernard, PL; Bersani, M; Berti, E; Bogatyrchuk, L; Bourret, R; Brehm, J; Brussino, L; Buhr, D; Bultje, D; Cabeza, E; Cano, A; De Capitani, C; Carantoña, E; Cardoso, A; Clavero, JIC; Combe, B; Conforti, D; Coppola, L; Corti, F; Coscioni, E; Costa, E; Crooks, G; Cunha, A; Daien, C; Dantas; Sierra, JD; Davoli, M; Baraldes, AD; De Luca, V; De Nardi, L; Di Ciano, M; Dozet, A; Ekinci, B; Erve, S; Espinoza, AJM; Fait, A; Fensli, R; Nocelo, SF; Gálvez-Daza, P; Gáamez-Payá, J; Sáez, MG; Sanchez, IG; Gemicioglu, B; Goetzke, W; Goossens, E; Geurdens, M; Gütter, Z; Hansen, H; Hartman, S; Hegendörfer, G; Heikka, H; Henderson, D; Héran, D; Hirvonen, S; Iaccarino, G; Jansson, N; Kallasvaara, H; Kalyoncu, F; Kirchmayer, U; Kokko, JA; Korpelainen, J; Kostka, T; Kuna, P; Ortega, TL; Lama, CM; Laune, D; Lauri, D; Ledroit, V; Levato, G; Lewis, L; Liotta, G; Lundgren, L; Lupiañez-Villanueva, F; Mc Garry, P; Maggio, M; de Keenoy, EM; Martinez, C; Martínez-Domene, M; Aranaga, BML; Massimilliano, M; Maurizio, A; Mayora, O; Melle, C; Mendez-Zorilla, A; Mengon, H; Mercier, G; Mercier, J; Meyer, I; Pi-Figueras, AM; Mitsias, P; Molloy, DW; Monti, R; Moro, ML; Muranko, H; Nalin, M; Nobili, A; Noguès, M; O'Caoimh, R; Pais, S; Papini, D; Parkkila, P; Pattichis, C; Pavlickova, A; Peiponen, A; Pereira, S; Pépin, JL; Jiménez, P; Portheine, P; Potel, L; Pozzi, AC; Quiñonez, P; Lauritsen, XR; Ramos, MJ; Rännäli-Kontturi, A; Risino, A; Robalo-Cordeiro, C; Rolla, G; Roller, R; Romano, M; Romano, V; Ruiz-Fernández, J; Saccavini, C; Sachinopoulou, A; Rubio, MJS; Santos, L; Scalvini, S; Scopetani, E; Smedberg, D; Solana-Lara, R; Soltysik, B; Sorlini, M; Stericker, S; Badiale, MS; Taillieu, I; Tervahauta, M; Teixeira, A; Tikanmäki, H; Todo-Bom, A; Tooley, A; Tuulonen, A; Tziraki, C; Ussai, S; Van der Veen, S; Venchiarutti, A; Verdoy-Berastegi, D; Verissimo, M; Visconti, L; Vollenbroek-Hutten, M; Weinzerl, K; Wozniak, L; Yorgancioglu, A; Zavagli, V; Zurkuhlen, AJ
    Seventy four Reference Sites of the European Innovation Partnership on Active and Healthy Ageing (EIP on AHA) have been recognised by the European Commission in 2016 for their commitment to excellence in investing and scaling up innovative solutions for active and healthy ageing. The Reference Site Collaborative Network (RSCN) brings together the EIP on AHA Reference Sites awarded by the European Commission, and Candidate Reference Sites into a single forum. The overarching goals are to promote cooperation, share and transfer good practice and solutions in the development and scaling up of health and care strategies, policies and service delivery models, while at the same time supporting the action groups in their work. The RSCN aspires to be recognized by the EU Commission as the principal forum and authority representing all EIP on AHA Reference Sites. The RSCN will contribute to achieve the goals of the EIP on AHA by improving health and care outcomes for citizens across Europe, and the development of sustainable economic growth and the creation of jobs.
  • No Thumbnail Available
    Item
    CHRODIS criteria applied to the MASK (MACVIA-ARIA Sentinel NetworK) Good Practice in allergic rhinitis: a SUNFRAIL report
    Bousquet, J; Onorato, GL; Bachert, C; Barbolini, M; Bedbrook, A; Bjermer, L; de Sousa, JC; Chavannes, NH; Cruz, AA; Keenoy, ED; Devillier, P; Fonseca, J; Hun, S; Kostka, T; Hellings, PW; Illario, M; Ivancevich, JC; Larenas-Linnemann, D; Millot-Keurinck, J; Ryan, D; Samolinski, B; Sheikh, A; Yorgancioglu, A; Agache, I; Arnavielhe, S; Bewick, M; Annesi-Maesano, I; Anto, JM; Bergmann, KC; Bindslev-Jensen, C; Bosnic-Anticevich, S; Bouchard, J; Caimmi, DP; Camargos, P; Canonica, GW; Cardona, V; Carriazo, AM; Cingi, C; Colgan, E; Custovic, A; Dahl, R; Demoly, P; De Vries, G; Fokkens, WJ; Fontaine, JF; Gemicioglu, B; Guldemond, N; Gutter, Z; Haahtela, T; Hellqvist-Dahl, B; Jares, E; Joos, G; Just, J; Khaltaev, N; Keil, T; Klimek, L; Kowalski, ML; Kull, I; Kuna, P; Kvedariene, V; Laune, D; Louis, R; Magnan, A; Malva, J; Mathieu-Dupas, E; Melén, E; Menditto, E; Morais-Almeida, M; Mösges, R; Mullol, J; Murray, R; Neffen, H; O'Hehir, R; Palkonen, S; Papadopoulos, NG; Passalacqua, G; Pépin, JL; Portejoie, F; Price, D; Pugin, B; Raciborski, F; Simons, FER; Sova, M; Spranger, O; Stellato, C; Bom, AT; Tomazic, PV; Triggiani, M; Valero, A; Valovirta, E; VandenPlas, O; Valiulis, A; Van Eerd, M; Ventura, MT; Wickman, M; Young, I; Zuberbier, T; Zurkuhlen, A; Senn, A
    A Good Practice is a practice that works well, produces good results, and is recommended as a model. MACVIA-ARIA Sentinel Network (MASK), the new Allergic Rhinitis and its Impact on Asthma (ARIA) initiative, is an example of a Good Practice focusing on the implementation of multi-sectoral care pathways using emerging technologies with real life data in rhinitis and asthma multi-morbidity. The European Union Joint Action on Chronic Diseases and Promoting Healthy Ageing across the Life Cycle (JA-CHRODIS) has developed a checklist of 28 items for the evaluation of Good Practices. SUNFRAIL (Reference Sites Network for Prevention and Care of Frailty and Chronic Conditions in community dwelling persons of EU Countries), a European Union project, assessed whether MASK is in line with the 28 items of JA-CHRODIS. A short summary was proposed for each item and 18 experts, all members of ARIA and SUNFRAIL from 12 countries, assessed the 28 items using a Survey Monkey-based questionnaire. A visual analogue scale (VAS) from 0 (strongly disagree) to 100 (strongly agree) was used. Agreement equal or over 75% was observed for 14 items (50%). MASK is following the JA-CHRODIS recommendations for the evaluation of Good Practices.